| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.56e-11 | 167 | 79 | 11 | GO:0031490 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 8.31e-09 | 67 | 79 | 7 | GO:0031492 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.20e-07 | 98 | 79 | 7 | GO:0031491 | |
| GeneOntologyMolecularFunction | chromatin binding | H1-10 ATRX KDM5A H1-2 H1-3 H1-4 H1-5 APEX1 HMGN1 H1-1 MPHOSPH8 CHD2 CHD7 MED1 BAHCC1 | 1.73e-07 | 739 | 79 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.37e-07 | 37 | 79 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 2.80e-06 | 100 | 79 | 6 | GO:0030527 | |
| GeneOntologyMolecularFunction | structural molecule activity | CYLC1 CYLC2 H1-10 RPL29 MAP1B MATR3 H1-2 H1-3 H1-4 H1-5 LAMA4 H1-1 RPS25 MRPL1 | 9.33e-06 | 891 | 79 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | histone binding | 1.00e-05 | 265 | 79 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | helicase activity | 3.85e-05 | 158 | 79 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.81e-05 | 339 | 79 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.04e-05 | 441 | 79 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.49e-04 | 127 | 79 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.50e-04 | 614 | 79 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 1.53e-04 | 5 | 79 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | methylated histone binding | 3.77e-04 | 86 | 79 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 4.11e-04 | 88 | 79 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 4.26e-04 | 8 | 79 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.88e-04 | 599 | 79 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.01e-04 | 262 | 79 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 9.37e-04 | 775 | 79 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.69e-03 | 562 | 79 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.70e-03 | 839 | 79 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.71e-03 | 840 | 79 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.71e-03 | 840 | 79 | 10 | GO:0016818 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.97e-03 | 134 | 79 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 3.95e-03 | 645 | 79 | 8 | GO:0140640 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 4.51e-03 | 84 | 79 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | histone reader activity | 4.72e-03 | 26 | 79 | 2 | GO:0140566 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H1-10 BRPF3 MED19 ATRX KDM5A RAD54B H1-2 H1-3 H1-4 H1-5 GATAD1 APEX1 HMGB1 CHD9 PHF14 HMGN1 H1-1 MPHOSPH8 CHD2 CHD7 MED1 IFI16 BAHCC1 | 1.21e-12 | 999 | 78 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | H1-10 BRPF3 ATRX KDM5A RAD54B H1-2 H1-3 H1-4 H1-5 GATAD1 APEX1 HMGB1 CHD9 PHF14 HMGN1 H1-1 MPHOSPH8 CHD2 CHD7 IFI16 BAHCC1 | 1.03e-11 | 896 | 78 | 21 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H1-10 BRPF3 ATRX KDM5A RAD54B H1-2 H1-3 H1-4 H1-5 GATAD1 APEX1 HMGB1 CHD9 H1-1 MPHOSPH8 CHD2 CHD7 IFI16 | 2.28e-10 | 741 | 78 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromosome condensation | 2.60e-08 | 48 | 78 | 6 | GO:0030261 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 3.36e-08 | 249 | 78 | 10 | GO:0065004 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 6.02e-08 | 55 | 78 | 6 | GO:0045910 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 6.46e-08 | 142 | 78 | 8 | GO:0034728 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 3.97e-07 | 122 | 78 | 7 | GO:0006334 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.24e-06 | 368 | 78 | 10 | GO:0006310 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.60e-06 | 150 | 78 | 7 | GO:0000018 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | H1-10 BRPF3 WAS ATRX RBBP6 RTF2 RAD54B H1-2 H1-3 H1-4 H1-5 APEX1 HMGB1 HMGN1 H1-1 XPC | 2.31e-06 | 1081 | 78 | 16 | GO:0006259 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 8.59e-06 | 564 | 78 | 11 | GO:0051052 | |
| GeneOntologyBiologicalProcess | chromosome organization | H1-10 ATRX RAD54B H1-2 H1-3 H1-4 H1-5 APEX1 HMGB1 H1-1 MPHOSPH8 GOLGA2 | 9.69e-06 | 686 | 78 | 12 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 2.69e-05 | 155 | 78 | 6 | GO:0051053 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX11 ING1 KDM5A TRO H1-2 H1-3 H1-4 H1-5 PLCB1 APEX1 HMGB1 PHF14 MPHOSPH8 MED1 IFI16 SPEN | 6.46e-05 | 1413 | 78 | 16 | GO:1902679 |
| GeneOntologyBiologicalProcess | pyrimidine dimer repair by nucleotide-excision repair | 8.43e-05 | 4 | 78 | 2 | GO:0000720 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX11 ING1 KDM5A TRO H1-2 H1-3 H1-4 H1-5 HMGB1 PHF14 MED1 IFI16 SPEN | 1.49e-04 | 1053 | 78 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX11 ING1 KDM5A TRO H1-2 H1-3 H1-4 H1-5 PLCB1 APEX1 HMGB1 PHF14 MED1 IFI16 SPEN | 2.07e-04 | 1399 | 78 | 15 | GO:0045892 |
| GeneOntologyCellularComponent | chromatin | SOX11 H1-10 BRPF3 ATRX ING1 KDM5A MYT1 H1-2 H1-3 H1-4 H1-5 PLCB1 PHF14 HMGN1 H1-1 MPHOSPH8 CHD2 CHD7 XPC MED1 AFF4 | 6.74e-08 | 1480 | 78 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | euchromatin | 2.85e-07 | 72 | 78 | 6 | GO:0000791 | |
| GeneOntologyCellularComponent | nucleosome | 8.38e-07 | 138 | 78 | 7 | GO:0000786 | |
| GeneOntologyCellularComponent | cytoskeletal calyx | 4.11e-05 | 3 | 78 | 2 | GO:0033150 | |
| GeneOntologyCellularComponent | perinuclear theca | 1.36e-04 | 5 | 78 | 2 | GO:0033011 | |
| GeneOntologyCellularComponent | ribosome | 4.89e-04 | 267 | 78 | 6 | GO:0005840 | |
| GeneOntologyCellularComponent | heterochromatin | 5.57e-04 | 101 | 78 | 4 | GO:0000792 | |
| MousePheno | increased cellular sensitivity to ultraviolet irradiation | 7.06e-06 | 26 | 68 | 4 | MP:0008410 | |
| MousePheno | increased cellular sensitivity to ionizing radiation | 4.52e-05 | 81 | 68 | 5 | MP:0004227 | |
| MousePheno | absent nasal pit | 6.97e-05 | 3 | 68 | 2 | MP:0030060 | |
| Domain | Histone_H5 | 1.12e-13 | 8 | 77 | 6 | IPR005819 | |
| Domain | H15 | 6.75e-12 | 13 | 77 | 6 | SM00526 | |
| Domain | Linker_histone | 6.75e-12 | 13 | 77 | 6 | PF00538 | |
| Domain | H15 | 6.75e-12 | 13 | 77 | 6 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.18e-11 | 14 | 77 | 6 | IPR005818 | |
| Domain | SNF2_N | 1.93e-07 | 32 | 77 | 5 | IPR000330 | |
| Domain | SNF2_N | 1.93e-07 | 32 | 77 | 5 | PF00176 | |
| Domain | Chromo_domain | 2.66e-06 | 24 | 77 | 4 | IPR023780 | |
| Domain | Chromo | 3.73e-06 | 26 | 77 | 4 | PF00385 | |
| Domain | CHROMO_1 | 5.07e-06 | 28 | 77 | 4 | PS00598 | |
| Domain | CHROMO_2 | 5.07e-06 | 28 | 77 | 4 | PS50013 | |
| Domain | Helicase_C | 5.23e-06 | 107 | 77 | 6 | PF00271 | |
| Domain | HELICc | 5.23e-06 | 107 | 77 | 6 | SM00490 | |
| Domain | Helicase_C | 5.52e-06 | 108 | 77 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 5.83e-06 | 109 | 77 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.83e-06 | 109 | 77 | 6 | PS51192 | |
| Domain | DEXDc | 5.83e-06 | 109 | 77 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.14e-06 | 110 | 77 | 6 | IPR014001 | |
| Domain | Chromodomain-like | 8.80e-06 | 32 | 77 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 9.98e-06 | 33 | 77 | 4 | IPR000953 | |
| Domain | CHROMO | 9.98e-06 | 33 | 77 | 4 | SM00298 | |
| Domain | Cylicin_N | 1.68e-05 | 2 | 77 | 2 | IPR029354 | |
| Domain | CYLC | 1.68e-05 | 2 | 77 | 2 | IPR026189 | |
| Domain | Cylicin_N | 1.68e-05 | 2 | 77 | 2 | PF15241 | |
| Domain | ZF_PHD_2 | 4.53e-05 | 95 | 77 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 4.76e-05 | 96 | 77 | 5 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 1.49e-04 | 65 | 77 | 4 | IPR019786 | |
| Domain | BRK | 2.49e-04 | 6 | 77 | 2 | SM00592 | |
| Domain | BRK_domain | 2.49e-04 | 6 | 77 | 2 | IPR006576 | |
| Domain | BRK | 2.49e-04 | 6 | 77 | 2 | PF07533 | |
| Domain | PHD | 2.60e-04 | 75 | 77 | 4 | PF00628 | |
| Domain | - | 2.81e-04 | 218 | 77 | 6 | 1.10.10.10 | |
| Domain | Znf_PHD-finger | 3.17e-04 | 79 | 77 | 4 | IPR019787 | |
| Domain | Znf_FYVE_PHD | 3.53e-04 | 147 | 77 | 5 | IPR011011 | |
| Domain | WHTH_DNA-bd_dom | 4.89e-04 | 242 | 77 | 6 | IPR011991 | |
| Domain | PHD | 5.00e-04 | 89 | 77 | 4 | SM00249 | |
| Domain | Znf_PHD | 5.44e-04 | 91 | 77 | 4 | IPR001965 | |
| Domain | P-loop_NTPase | KIF9 ABCF1 ATRX DDX52 RAD54B PSMC1 EIF5B CHD9 CHD2 CHD7 ABCC2 | 6.83e-04 | 848 | 77 | 11 | IPR027417 |
| Domain | - | 9.50e-04 | 746 | 77 | 10 | 3.40.50.300 | |
| Domain | GATA_ZN_FINGER_1 | 1.94e-03 | 16 | 77 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 1.94e-03 | 16 | 77 | 2 | PS50114 | |
| Domain | Chromodomain_CS | 2.46e-03 | 18 | 77 | 2 | IPR023779 | |
| Domain | - | 2.50e-03 | 449 | 77 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.83e-03 | 459 | 77 | 7 | IPR013083 | |
| Domain | EPHD | 3.67e-03 | 22 | 77 | 2 | PS51805 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 6.24e-12 | 13 | 58 | 6 | M1018 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 7.66e-10 | 12 | 58 | 5 | MM14554 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 5.89e-09 | 17 | 58 | 5 | M27189 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 6.54e-08 | 52 | 58 | 6 | M2341 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 3.40e-07 | 15 | 58 | 4 | MM14902 | |
| Pathway | REACTOME_APOPTOSIS | 6.45e-07 | 179 | 58 | 8 | M15303 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.64e-06 | 49 | 58 | 5 | MM15448 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 2.22e-06 | 211 | 58 | 8 | M27436 | |
| Pathway | REACTOME_APOPTOSIS | 5.15e-06 | 108 | 58 | 6 | MM14471 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.77e-05 | 79 | 58 | 5 | M27191 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 2.47e-05 | 142 | 58 | 6 | MM15178 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 7.00e-05 | 54 | 58 | 4 | MM14904 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 MED19 NOP56 ATRX MAP1B ING1 RBBP6 ANLN RTF2 MATR3 KTN1 H1-2 CAST EIF5B APEX1 HMGB1 PHF14 HMGN1 MPHOSPH8 NCL CHD7 RPS25 MED1 RRBP1 MDK SPEN PPIB MRPL1 AFF4 | 3.04e-25 | 954 | 79 | 29 | 36373674 |
| Pubmed | CYLC1 CYLC2 C9orf43 AKAP5 NOP56 ATRX MAP1B KDM5A TRO DDX52 MATR3 KTN1 H1-2 H1-3 H1-4 H1-5 EIF5B HMGB1 PHF14 H1-1 MPHOSPH8 CHD2 NCL XPC RPS25 ABCC2 RRBP1 SPAG17 PNISR SPEN PPIB CDK5R2 BAHCC1 | 5.00e-25 | 1442 | 79 | 33 | 35575683 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | H1-10 RPL29 NOP56 ATRX TCOF1 ING1 KDM5A RBBP6 DDX52 MATR3 KTN1 H1-2 H1-4 H1-5 GATAD1 HMGB1 PHF14 HMGN1 MPHOSPH8 CHD2 NCL CHD7 XPC RPS25 MED1 RRBP1 IFI16 PNISR SPEN | 1.45e-21 | 1294 | 79 | 29 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ABCF1 NOP56 MAP1B TCOF1 SLC16A1 KDM5A RBBP6 MATR3 EIF5B APEX1 HMGB1 CHD9 HMGN1 MPHOSPH8 CHD2 NCL CHD7 XPC RPS25 MED1 MDK PNISR SPEN PPIB AFF4 | 8.07e-19 | 1082 | 79 | 25 | 38697112 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 RPL29 ABCF1 NOP56 TCOF1 RBBP6 DDX52 MATR3 H1-2 H1-3 H1-4 EIF5B APEX1 HMGB1 CHD2 NCL RPS25 RRBP1 PNISR SPEN PPIB MRPL1 | 4.70e-18 | 807 | 79 | 22 | 22681889 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | H1-10 RPL29 MED19 ABCF1 NOP56 TCOF1 SLC16A1 KDM5A RBBP6 DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 EIF5B HMGB1 CHD2 NCL CHD7 RPS25 RRBP1 PPIB MRPL1 | 6.55e-18 | 1318 | 79 | 26 | 30463901 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | H1-10 RPL29 ABCF1 NOP56 MAP1B NCKAP1 SLC16A1 ANLN DDX52 RTF2 MATR3 KTN1 H1-2 LARS1 H1-5 PSMC1 EIF5B H1-1 CHD2 NCL CHD7 XPC RPS25 RRBP1 IFI16 PPIB | 1.24e-17 | 1353 | 79 | 26 | 29467282 |
| Pubmed | H1-10 RPL29 ABCF1 TCOF1 MATR3 KTN1 H1-2 H1-4 H1-5 EIF5B HMGB1 NCL RPS25 RRBP1 NMT1 PPIB | 2.00e-17 | 317 | 79 | 16 | 30997501 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | H1-10 ABCF1 ATRX TCOF1 KDM5A RBBP6 ANLN MATR3 CAST EIF5B PHF14 HMGN1 NCL CHD7 XPC MED1 RRBP1 IFI16 NMT1 PNISR SPEN | 3.35e-17 | 774 | 79 | 21 | 15302935 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | H1-10 RPL29 ABCF1 NOP56 MATR3 KTN1 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B APEX1 HMGB1 ZNF561 NCL RPS25 RRBP1 SPAG17 NMT1 PPIB | 7.73e-17 | 807 | 79 | 21 | 30575818 |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 1.13e-16 | 6 | 79 | 6 | 15595731 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | H1-10 RPL29 ABCF1 NOP56 SLC16A1 RBBP6 ANLN DDX52 MATR3 H1-3 LARS1 H1-5 PSMC1 EIF5B GATAD1 HMGB1 NCL RPS25 RRBP1 IFI16 NMT1 SPEN PPIB GOLGA2 | 3.37e-16 | 1257 | 79 | 24 | 36526897 |
| Pubmed | H1-10 RPL29 ABCF1 NOP56 MAP1B TCOF1 SLC16A1 MATR3 KTN1 H1-2 H1-3 LARS1 EIF5B CHD9 NCL RPS25 RRBP1 PPIB GOLGA2 | 1.79e-14 | 809 | 79 | 19 | 32129710 | |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 2.36e-14 | 10 | 79 | 6 | 28794128 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H1-10 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 RBBP6 DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B NCL RPS25 RRBP1 IFI16 PPIB | 2.50e-14 | 949 | 79 | 20 | 36574265 |
| Pubmed | H1-10 RPL29 ABCF1 TCOF1 RBBP6 DDX52 MATR3 KTN1 H1-2 H1-3 LARS1 H1-4 EIF5B APEX1 HMGB1 CHD9 NCL RPS25 MED1 RRBP1 GOLGA2 AFF4 | 3.69e-14 | 1247 | 79 | 22 | 27684187 | |
| Pubmed | H1-10 RPL29 NOP56 TCOF1 SLC16A1 RBBP6 DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 HMGN1 NCL RPS25 NMT1 SPEN PPIB | 4.34e-14 | 731 | 79 | 18 | 29298432 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 5.18e-14 | 11 | 79 | 6 | 26689747 | |
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 5.32e-14 | 5 | 79 | 5 | 9300059 | |
| Pubmed | 5.32e-14 | 5 | 79 | 5 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 5.32e-14 | 5 | 79 | 5 | 8003976 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 5.32e-14 | 5 | 79 | 5 | 9655912 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 1.03e-13 | 12 | 79 | 6 | 22650316 | |
| Pubmed | MED19 ABCF1 ATRX NCKAP1 KDM5A RBBP6 ANLN DDX52 KTN1 PSMC1 EIF5B GATAD1 APEX1 PHF14 MPHOSPH8 CHD2 CHD7 XPC MED1 NMT1 PNISR SPEN AFF4 | 1.54e-13 | 1497 | 79 | 23 | 31527615 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H1-10 NOP56 ATRX MAP1B DDX52 H1-2 LARS1 CHD9 PHF14 CHD2 CHD7 XPC MED1 RRBP1 | 2.91e-13 | 394 | 79 | 14 | 27248496 |
| Pubmed | 3.18e-13 | 6 | 79 | 5 | 15562002 | ||
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 3.18e-13 | 6 | 79 | 5 | 21425800 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 3.18e-13 | 6 | 79 | 5 | 11479299 | |
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 3.18e-13 | 6 | 79 | 5 | 9499577 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 3.18e-13 | 6 | 79 | 5 | 15911621 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | H1-10 ABCF1 NOP56 NCKAP1 TCOF1 SLC16A1 RTF2 MATR3 KTN1 H1-2 CAST LARS1 H1-5 PSMC1 EIF5B APEX1 NCL RPS25 RRBP1 NMT1 PPIB GOLGA2 | 4.64e-13 | 1415 | 79 | 22 | 28515276 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | FSIP2 ATRX KDM5A ANLN RAD54B GATAD1 APEX1 CHD9 PHF14 MPHOSPH8 CHD2 CHD7 XPC MED1 SPEN AFF4 | 4.88e-13 | 608 | 79 | 16 | 36089195 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | H1-10 RPL29 ABCF1 NOP56 ATRX NCKAP1 TCOF1 SLC16A1 DDX52 MATR3 KTN1 H1-2 LARS1 PSMC1 EIF5B HMGB1 MPHOSPH8 NCL RPS25 RRBP1 SPEN PPIB | 5.33e-13 | 1425 | 79 | 22 | 30948266 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | H1-10 RPL29 ABCF1 NOP56 MAP1B NCKAP1 TCOF1 MATR3 H1-2 CAST LARS1 PSMC1 EIF5B APEX1 HMGB1 NCL RPS25 MDK NMT1 PPIB | 8.51e-13 | 1149 | 79 | 20 | 35446349 |
| Pubmed | 8.90e-13 | 16 | 79 | 6 | 33288900 | ||
| Pubmed | H1-10 RPL29 NOP56 TCOF1 KDM5A MATR3 H1-2 H1-3 LARS1 H1-4 PSMC1 HMGB1 CHD9 H1-1 CHD2 NCL CHD7 RPS25 MED1 PPIB | 9.06e-13 | 1153 | 79 | 20 | 29845934 | |
| Pubmed | MED19 ATRX RBBP6 RTF2 MATR3 H1-2 H1-5 EIF5B APEX1 HMGB1 CHD9 PHF14 HMGN1 MPHOSPH8 CHD2 NCL MED1 RRBP1 IFI16 | 9.71e-13 | 1014 | 79 | 19 | 32416067 | |
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 1.11e-12 | 7 | 79 | 5 | 8325638 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL29 ABCF1 NOP56 ATRX MAP1B TCOF1 RBBP6 MATR3 KTN1 CAST LARS1 H1-4 EIF5B NCL MED1 RRBP1 NMT1 AFF4 | 2.65e-12 | 934 | 79 | 18 | 33916271 |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | H1-10 RPL29 NOP56 TCOF1 SLC16A1 DDX52 MATR3 H1-2 H1-3 H1-4 PSMC1 HMGN1 NCL RPS25 PPIB | 6.43e-12 | 604 | 79 | 15 | 37616343 |
| Pubmed | H1-10 RPL29 ABCF1 NCKAP1 TCOF1 MATR3 KTN1 H1-2 LARS1 EIF5B H1-1 NCL RPS25 RRBP1 PPIB | 8.30e-12 | 615 | 79 | 15 | 31048545 | |
| Pubmed | H1-10 RPL29 NOP56 ATRX ANLN DDX52 RTF2 H1-2 H1-3 H1-4 H1-5 APEX1 PPIB | 1.20e-11 | 419 | 79 | 13 | 15635413 | |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 1.33e-11 | 10 | 79 | 5 | 15927069 | |
| Pubmed | H1-10 RPL29 NOP56 ATRX TCOF1 RBBP6 MATR3 H1-2 H1-4 H1-5 PSMC1 HMGN1 NCL RPS25 PPIB | 1.89e-11 | 652 | 79 | 15 | 31180492 | |
| Pubmed | H1-10 RPL29 ABCF1 NOP56 TCOF1 RBBP6 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B NCL RRBP1 | 2.01e-11 | 655 | 79 | 15 | 35819319 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 19072710 | ||
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 11746507 | ||
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 10997781 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RPL29 MED19 WAS RBBP6 RTF2 MATR3 KTN1 LARS1 H1-5 HMGN1 MPHOSPH8 NCL MED1 PNISR GOLGA2 | 5.19e-11 | 701 | 79 | 15 | 30196744 |
| Pubmed | 6.75e-11 | 13 | 79 | 5 | 8858344 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL29 NOP56 NCKAP1 TRO MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 HMGB1 H1-1 NCL RPS25 PPIB | 6.87e-11 | 847 | 79 | 16 | 35235311 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H1-10 RPL29 ABCF1 NOP56 MAP1B TCOF1 DDX52 MATR3 LARS1 H1-4 PSMC1 EIF5B NCL RPS25 RRBP1 SPEN PPIB | 1.18e-10 | 1024 | 79 | 17 | 24711643 |
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 1.23e-10 | 5 | 79 | 4 | 10893414 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.33e-10 | 231 | 79 | 10 | 16452087 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL29 NOP56 MAP1B TCOF1 MATR3 H1-2 H1-4 H1-5 PSMC1 MPHOSPH8 NCL CHD7 RPS25 RRBP1 | 1.38e-10 | 626 | 79 | 14 | 33644029 |
| Pubmed | MED19 NOP56 TCOF1 KDM5A DDX52 MATR3 KTN1 HMGN1 CHD2 NCL CHD7 XPC MED1 RRBP1 MDK NMT1 PPIB GOLGA2 AFF4 | 1.71e-10 | 1371 | 79 | 19 | 36244648 | |
| Pubmed | H1-10 RPL29 ABCF1 MAP1B KTN1 H1-4 PSMC1 EIF5B NCL RRBP1 IFI16 PPIB | 1.92e-10 | 418 | 79 | 12 | 35338135 | |
| Pubmed | H1-10 RPL29 ABCF1 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 NCL RPS25 MRPL1 | 2.33e-10 | 425 | 79 | 12 | 21081503 | |
| Pubmed | H1-10 ABCF1 MAP1B NCKAP1 TCOF1 DDX52 H1-3 H1-4 EIF5B H1-1 CHD2 NCL CHD7 SPEN | 2.39e-10 | 653 | 79 | 14 | 22586326 | |
| Pubmed | MAP1B H1-2 H1-3 LARS1 H1-4 PSMC1 EIF5B PHF14 RPS25 RRBP1 NMT1 | 2.75e-10 | 334 | 79 | 11 | 30425250 | |
| Pubmed | H1-10 RPL29 ABCF1 ATRX TCOF1 MATR3 H1-2 H1-3 H1-4 EIF5B NCL MED1 | 3.54e-10 | 441 | 79 | 12 | 31239290 | |
| Pubmed | ABCF1 ANLN RTF2 H1-2 LARS1 H1-5 PSMC1 EIF5B APEX1 HMGB1 CHD9 HMGN1 CHD7 MED1 IFI16 SPEN PPIB | 3.69e-10 | 1103 | 79 | 17 | 34189442 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | H1-10 ABCF1 NOP56 ATRX MAP1B DDX52 H1-2 H1-4 PSMC1 PHF14 IFI16 | 4.37e-10 | 349 | 79 | 11 | 25665578 |
| Pubmed | NOP56 NCKAP1 TCOF1 RBBP6 ANLN RTF2 H1-2 LARS1 H1-4 H1-5 PSMC1 EIF5B APEX1 HMGB1 NCL RPS25 RRBP1 SHOC2 | 5.52e-10 | 1297 | 79 | 18 | 33545068 | |
| Pubmed | H1-10 ABCF1 NCKAP1 MATR3 KTN1 H1-2 H1-4 APEX1 HMGB1 NCL RRBP1 NMT1 PPIB GOLGA2 | 7.17e-10 | 711 | 79 | 14 | 33022573 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | H1-10 RPL29 WAS NOP56 MAP1B DDX52 MATR3 H1-2 H1-4 PSMC1 H1-1 NCL RPS25 PPIB | 7.57e-10 | 714 | 79 | 14 | 28302793 |
| Pubmed | 8.58e-10 | 7 | 79 | 4 | 24435047 | ||
| Pubmed | H1-10 RPL29 ABCF1 MAP1B TCOF1 SLC16A1 DDX52 MATR3 H1-2 LARS1 H1-4 PSMC1 EIF5B H1-1 NCL RPS25 RRBP1 MRPL1 | 8.73e-10 | 1335 | 79 | 18 | 29229926 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NOP56 MAP1B KDM5A KTN1 CAST H1-5 EIF5B XPC RPS25 MED1 RRBP1 NMT1 SPEN PPIB | 9.05e-10 | 724 | 79 | 14 | 36232890 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.54e-10 | 283 | 79 | 10 | 30585729 | |
| Pubmed | H1-10 RPL29 ABCF1 NOP56 MATR3 KTN1 H1-5 EIF5B NCL RPS25 IFI16 NMT1 GOLGA2 | 1.00e-09 | 601 | 79 | 13 | 33658012 | |
| Pubmed | 1.30e-09 | 88 | 79 | 7 | 26318153 | ||
| Pubmed | ABCF1 TCOF1 RBBP6 ANLN EIF5B NCL MED1 RRBP1 IFI16 NMT1 SPEN GOLGA2 | 1.57e-09 | 503 | 79 | 12 | 16964243 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | H1-10 ABCF1 NOP56 MAP1B RBBP6 DDX52 MATR3 KTN1 LARS1 H1-4 NCL RPS25 MED1 RRBP1 | 1.66e-09 | 759 | 79 | 14 | 35915203 |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 2.41e-09 | 96 | 79 | 7 | 25948554 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.75e-09 | 316 | 79 | 10 | 31665637 | |
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 3.08e-09 | 9 | 79 | 4 | 24412544 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 3.36e-09 | 56 | 79 | 6 | 26919559 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | H1-10 RPL29 NOP56 MAP1B RBBP6 TRO DDX52 MATR3 H1-4 EIF5B NCL RPS25 MRPL1 | 4.25e-09 | 678 | 79 | 13 | 30209976 |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 4.42e-09 | 332 | 79 | 10 | 30595499 | |
| Pubmed | H1-10 RPL29 NOP56 TCOF1 RBBP6 DDX52 MATR3 KTN1 H1-4 NCL XPC RPS25 IFI16 GOLGA2 | 6.67e-09 | 847 | 79 | 14 | 35850772 | |
| Pubmed | NOP56 MAP1B NCKAP1 TCOF1 SLC16A1 KTN1 LARS1 H1-4 PSMC1 EIF5B RPS25 RRBP1 PPIB | 7.11e-09 | 708 | 79 | 13 | 39231216 | |
| Pubmed | H1-10 NOP56 SLC16A1 MATR3 H1-2 H1-3 LARS1 H1-4 PSMC1 NCL RPS25 | 8.29e-09 | 463 | 79 | 11 | 34901782 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL29 ABCF1 MAP1B NCKAP1 TCOF1 SLC16A1 ANLN KTN1 H1-2 PSMC1 EIF5B APEX1 H1-1 NCL RPS25 NMT1 PPIB | 9.20e-09 | 1367 | 79 | 17 | 32687490 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | H1-10 RPL29 MAP1B SLC16A1 H1-2 H1-3 H1-4 PSMC1 NCL RPS25 SPEN | 9.25e-09 | 468 | 79 | 11 | 36042349 |
| Pubmed | H1-10 RPL29 ABCF1 MAP1B SLC16A1 MATR3 KTN1 LARS1 H1-4 EIF5B NCL RPS25 RRBP1 | 9.41e-09 | 725 | 79 | 13 | 27025967 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 26209608 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 2613692 | ||
| Pubmed | High-resolution mapping of h1 linker histone variants in embryonic stem cells. | 1.13e-08 | 3 | 79 | 3 | 23633960 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 24525734 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 21245380 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18056081 | ||
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 1.34e-08 | 191 | 79 | 8 | 21907836 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | H1-10 ABCF1 NOP56 SLC16A1 DDX52 MATR3 H1-2 EIF5B NCL RRBP1 NMT1 | 1.36e-08 | 486 | 79 | 11 | 30940648 |
| Pubmed | 1.37e-08 | 123 | 79 | 7 | 35583604 | ||
| Pubmed | RPL29 NOP56 TCOF1 MATR3 LARS1 PSMC1 EIF5B APEX1 CHD9 NCL RPS25 | 1.61e-08 | 494 | 79 | 11 | 26831064 | |
| Pubmed | 1.62e-08 | 281 | 79 | 9 | 26725010 | ||
| Pubmed | 1.85e-08 | 74 | 79 | 6 | 36180920 | ||
| Pubmed | H1-10 NCKAP1 TCOF1 ING1 RBBP6 ANLN LARS1 H1-4 HMGB1 MED1 PNISR | 2.06e-08 | 506 | 79 | 11 | 30890647 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | H1-10 RPL29 ABCF1 NCKAP1 KTN1 H1-2 CAST LARS1 H1-4 H1-5 PSMC1 EIF5B APEX1 NCL RPS25 NMT1 PPIB | 2.29e-08 | 1455 | 79 | 17 | 22863883 |
| Interaction | SMC5 interactions | H1-10 MED19 NOP56 ATRX MAP1B ING1 RBBP6 ANLN RTF2 MATR3 KTN1 H1-2 CAST H1-5 EIF5B APEX1 HMGB1 PHF14 HMGN1 H1-1 MPHOSPH8 NCL CHD7 RPS25 MED1 RRBP1 MDK SPEN PPIB MRPL1 AFF4 | 1.33e-20 | 1000 | 78 | 31 | int:SMC5 |
| Interaction | MECP2 interactions | RPL29 ABCF1 NOP56 ATRX MAP1B TCOF1 SLC16A1 KDM5A RBBP6 ANLN MATR3 EIF5B APEX1 HMGB1 CHD9 PHF14 HMGN1 MPHOSPH8 CHD2 NCL CHD7 XPC RPS25 MED1 MDK PNISR SPEN PPIB AFF4 | 1.66e-15 | 1287 | 78 | 29 | int:MECP2 |
| Interaction | H2BC9 interactions | CYLC1 FSIP2 H1-10 ABCF1 ATRX MAP1B TRO H1-2 H1-3 H1-4 H1-5 HMGB1 HMGN1 H1-1 RRBP1 SPAG17 CDK5R2 GOLGA2 AFF4 | 4.96e-15 | 446 | 78 | 19 | int:H2BC9 |
| Interaction | H3C1 interactions | CYLC2 SOX11 H1-10 RPL29 AKAP5 ATRX KDM5A ANLN DDX52 RTF2 H1-2 CAST H1-3 H1-4 H1-5 HMGB1 HMGN1 H1-1 MPHOSPH8 CHD7 XPC RRBP1 SPEN AFF4 | 2.39e-14 | 901 | 78 | 24 | int:H3C1 |
| Interaction | H2BC21 interactions | CYLC1 H1-10 BRPF3 ATRX MAP1B DDX52 H1-2 H1-3 H1-4 H1-5 GATAD1 PHF14 H1-1 MPHOSPH8 NCL CHD7 XPC IFI16 CDK5R2 BAHCC1 | 1.34e-12 | 696 | 78 | 20 | int:H2BC21 |
| Interaction | H2BC12 interactions | CYLC1 H1-10 ABCF1 ATRX MAP1B ANLN TRO H1-2 H1-3 H1-4 EIF5B HMGN1 NCL SPAG17 CDK5R2 | 1.44e-12 | 322 | 78 | 15 | int:H2BC12 |
| Interaction | CEBPB interactions | H1-10 RPL29 ABCF1 NOP56 TCOF1 MATR3 KTN1 H1-2 CAST H1-3 LARS1 H1-4 H1-5 PSMC1 EIF5B APEX1 HMGB1 PHF14 NCL CHD7 XPC RPS25 MED1 RRBP1 IFI16 NMT1 PPIB | 1.81e-12 | 1443 | 78 | 27 | int:CEBPB |
| Interaction | EED interactions | H1-10 RPL29 ABCF1 NOP56 MAP1B NCKAP1 TCOF1 SLC16A1 KDM5A RBBP6 ANLN DDX52 MATR3 H1-2 LARS1 H1-4 PSMC1 EIF5B GATAD1 APEX1 H1-1 CHD2 NCL CHD7 RPS25 SPEN PPIB | 1.87e-12 | 1445 | 78 | 27 | int:EED |
| Interaction | H2BC5 interactions | CYLC1 ABCF1 MAP1B NCKAP1 TCOF1 DDX52 H1-2 H1-3 H1-4 H1-5 HMGN1 NCL XPC IFI16 CDK5R2 | 2.14e-12 | 331 | 78 | 15 | int:H2BC5 |
| Interaction | H3-3A interactions | ATRX KDM5A ANLN H1-2 H1-3 H1-4 H1-5 GATAD1 HMGB1 CHD9 PHF14 H1-1 MPHOSPH8 CHD2 NCL CHD7 XPC MED1 SPEN AFF4 | 5.12e-12 | 749 | 78 | 20 | int:H3-3A |
| Interaction | NR2C2 interactions | H1-10 RPL29 MED19 ABCF1 NOP56 TCOF1 SLC16A1 KDM5A RBBP6 DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 EIF5B HMGB1 CHD2 NCL CHD7 RPS25 RRBP1 PPIB MRPL1 | 6.63e-12 | 1403 | 78 | 26 | int:NR2C2 |
| Interaction | NPM1 interactions | H1-10 RPL29 AKAP5 NOP56 MAP1B NCKAP1 ANLN DDX52 MYT1 KTN1 H1-2 H1-3 H1-4 H1-5 APEX1 HMGB1 H1-1 NCL XPC RPS25 RRBP1 MDK MRPL1 GOLGA2 | 1.14e-11 | 1201 | 78 | 24 | int:NPM1 |
| Interaction | H2AC18 interactions | CYLC2 RPL29 MAP1B NCKAP1 ANLN H1-2 H1-3 H1-4 H1-5 HMGB1 H1-1 | 1.17e-11 | 148 | 78 | 11 | int:H2AC18 |
| Interaction | H3C15 interactions | FSIP2 KDM5A TRO H1-2 H1-3 H1-4 H1-5 HMGB1 HMGN1 H1-1 NCL RRBP1 | 2.40e-11 | 207 | 78 | 12 | int:H3C15 |
| Interaction | MYCN interactions | H1-10 RPL29 BRPF3 ABCF1 NOP56 MAP1B TCOF1 SLC16A1 RBBP6 DDX52 MATR3 KTN1 H1-2 H1-4 H1-5 PSMC1 EIF5B HMGB1 CHD2 NCL CHD7 RPS25 MDK PPIB MRPL1 | 2.80e-11 | 1373 | 78 | 25 | int:MYCN |
| Interaction | AGR2 interactions | H1-10 RPL29 ABCF1 NOP56 MATR3 KTN1 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B APEX1 HMGB1 ZNF561 NCL RPS25 RRBP1 SPAG17 NMT1 PPIB | 3.44e-11 | 934 | 78 | 21 | int:AGR2 |
| Interaction | RSL1D1 interactions | CYLC2 H1-10 NOP56 ANLN DDX52 MATR3 H1-2 CAST H1-3 H1-4 H1-5 APEX1 HMGB1 H1-1 NCL IFI16 | 3.59e-11 | 479 | 78 | 16 | int:RSL1D1 |
| Interaction | H1-4 interactions | RPL29 AKAP5 NOP56 TCOF1 ANLN H1-2 H1-3 H1-4 H1-5 EIF5B HMGB1 HMGN1 H1-1 NCL RPS25 SPAG17 IFI16 NMT1 | 4.59e-11 | 656 | 78 | 18 | int:H1-4 |
| Interaction | HMGN2 interactions | CYLC2 ABCF1 DDX52 H1-2 CAST H1-4 H1-5 APEX1 HMGN1 H1-1 LRRIQ4 SHOC2 | 5.43e-11 | 222 | 78 | 12 | int:HMGN2 |
| Interaction | ZC3H18 interactions | H1-10 RPL29 NOP56 TCOF1 SLC16A1 RBBP6 ANLN DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 HMGB1 HMGN1 NCL RPS25 NMT1 SPEN PPIB | 8.68e-11 | 877 | 78 | 20 | int:ZC3H18 |
| Interaction | LARP7 interactions | H1-10 RPL29 NOP56 NCKAP1 TCOF1 KDM5A H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 HMGB1 CHD9 H1-1 CHD2 NCL CHD7 XPC RPS25 IFI16 PPIB | 1.26e-10 | 1113 | 78 | 22 | int:LARP7 |
| Interaction | DDX23 interactions | NOP56 MAP1B TCOF1 RBBP6 DDX52 MATR3 APEX1 HMGB1 CHD2 NCL XPC IFI16 PNISR PPIB AFF4 | 4.00e-10 | 480 | 78 | 15 | int:DDX23 |
| Interaction | RPS2 interactions | RPL29 NOP56 MAP1B ANLN TRO MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 HMGB1 H1-1 NCL RPS25 IFI16 | 4.25e-10 | 657 | 78 | 17 | int:RPS2 |
| Interaction | NOP56 interactions | H1-10 ABCF1 NOP56 ATRX TCOF1 ANLN DDX52 H1-3 H1-4 APEX1 NCL RPS25 IFI16 NMT1 PPIB AFF4 | 4.62e-10 | 570 | 78 | 16 | int:NOP56 |
| Interaction | PRC1 interactions | H1-10 RPL29 ABCF1 NOP56 ATRX RBBP6 ANLN DDX52 MATR3 KTN1 H1-2 H1-3 H1-4 H1-5 EIF5B PHF14 HMGN1 NCL SPEN PPIB | 5.39e-10 | 973 | 78 | 20 | int:PRC1 |
| Interaction | EFTUD2 interactions | H1-10 ABCF1 NOP56 NCKAP1 TCOF1 ANLN RTF2 MATR3 KTN1 H1-2 CAST LARS1 H1-5 PSMC1 EIF5B APEX1 HMGB1 NCL RPS25 RRBP1 IFI16 NMT1 PPIB GOLGA2 | 5.44e-10 | 1449 | 78 | 24 | int:EFTUD2 |
| Interaction | CIT interactions | H1-10 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 RBBP6 ANLN MATR3 KTN1 H1-2 H1-3 H1-4 H1-5 EIF5B HMGN1 MPHOSPH8 CHD2 NCL RPS25 MED1 SPAG17 IFI16 PPIB | 5.51e-10 | 1450 | 78 | 24 | int:CIT |
| Interaction | RPL7A interactions | H1-10 RPL29 C9orf43 NOP56 ATRX ANLN MATR3 LARS1 H1-4 EIF5B APEX1 HMGB1 H1-1 NCL CHD7 RPS25 IFI16 | 7.02e-10 | 679 | 78 | 17 | int:RPL7A |
| Interaction | CDK7 interactions | H1-10 RPL29 MAP1B SLC16A1 ANLN DDX52 H1-2 H1-3 H1-4 H1-1 NCL XPC MED1 PNISR SPEN | 7.21e-10 | 501 | 78 | 15 | int:CDK7 |
| Interaction | NSD2 interactions | RPL29 ATRX MAP1B TCOF1 H1-2 H1-4 H1-5 APEX1 HMGB1 H1-1 NCL IFI16 | 7.24e-10 | 278 | 78 | 12 | int:NSD2 |
| Interaction | H2AC4 interactions | H1-10 NOP56 ATRX DDX52 H1-2 H1-3 LARS1 H1-4 H1-5 CHD9 PHF14 HMGN1 H1-1 CHD2 XPC | 8.26e-10 | 506 | 78 | 15 | int:H2AC4 |
| Interaction | DAXX interactions | ABCF1 ATRX H1-2 H1-5 APEX1 CHD9 PHF14 H1-1 MPHOSPH8 NCL SPEN GOLGA2 AFF4 | 9.27e-10 | 353 | 78 | 13 | int:DAXX |
| Interaction | NCL interactions | H1-10 RPL29 AKAP5 NOP56 ANLN H1-2 H1-3 H1-4 H1-5 EIF5B APEX1 HMGB1 H1-1 NCL RPS25 RRBP1 MDK IFI16 | 1.08e-09 | 798 | 78 | 18 | int:NCL |
| Interaction | PYHIN1 interactions | H1-10 RPL29 ABCF1 ATRX MAP1B TCOF1 SLC16A1 H1-2 H1-4 EIF5B LAMA4 PHF14 SPEN | 1.10e-09 | 358 | 78 | 13 | int:PYHIN1 |
| Interaction | H1-3 interactions | H1-10 NOP56 ATRX ANLN H1-2 H1-3 H1-4 H1-5 H1-1 NCL RPS25 IFI16 | 1.22e-09 | 291 | 78 | 12 | int:H1-3 |
| Interaction | DOT1L interactions | H1-10 RPL29 NOP56 ATRX TCOF1 RBBP6 DDX52 MATR3 KTN1 H1-2 H1-4 APEX1 H1-1 NCL XPC RPS25 IFI16 GOLGA2 | 1.29e-09 | 807 | 78 | 18 | int:DOT1L |
| Interaction | RBM39 interactions | H1-10 RPL29 WAS NOP56 ATRX MAP1B ANLN DDX52 MATR3 H1-2 H1-4 PSMC1 HMGB1 H1-1 NCL RPS25 IFI16 PNISR PPIB GOLGA2 | 1.76e-09 | 1042 | 78 | 20 | int:RBM39 |
| Interaction | MACROH2A1 interactions | ATRX MAP1B ANLN MATR3 H1-2 H1-4 APEX1 HMGB1 PHF14 HMGN1 H1-1 NCL XPC IFI16 | 2.18e-09 | 458 | 78 | 14 | int:MACROH2A1 |
| Interaction | H2AC11 interactions | 2.95e-09 | 248 | 78 | 11 | int:H2AC11 | |
| Interaction | METTL14 interactions | ABCF1 NOP56 NCKAP1 SLC16A1 ANLN MATR3 KTN1 H1-2 LARS1 PSMC1 APEX1 MPHOSPH8 NCL RPS25 PPIB | 3.13e-09 | 558 | 78 | 15 | int:METTL14 |
| Interaction | NAA40 interactions | RPL29 ABCF1 NOP56 ATRX MAP1B TCOF1 RBBP6 MATR3 KTN1 CAST LARS1 H1-4 EIF5B NCL XPC MED1 RRBP1 NMT1 AFF4 | 4.02e-09 | 978 | 78 | 19 | int:NAA40 |
| Interaction | TNIP1 interactions | H1-10 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 RBBP6 DDX52 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B LAMA4 NCL RPS25 RRBP1 IFI16 PPIB | 4.22e-09 | 1217 | 78 | 21 | int:TNIP1 |
| Interaction | H1-2 interactions | H1-10 RPL29 AKAP5 ATRX TCOF1 H1-2 CAST H1-3 H1-4 H1-5 APEX1 H1-1 NCL SHOC2 IFI16 SLCO6A1 | 4.33e-09 | 666 | 78 | 16 | int:H1-2 |
| Interaction | H2BC4 interactions | FSIP2 H1-10 ABCF1 MAP1B TRO H1-2 H1-3 HMGN1 NCL SPAG17 CDK5R2 | 4.65e-09 | 259 | 78 | 11 | int:H2BC4 |
| Interaction | POU5F1 interactions | RPL29 ABCF1 TCOF1 MATR3 H1-2 H1-3 H1-5 EIF5B HMGB1 NCL CHD7 XPC RPS25 SHOC2 PPIB | 5.78e-09 | 584 | 78 | 15 | int:POU5F1 |
| Interaction | H3C3 interactions | FSIP2 ATRX KDM5A ANLN RAD54B GATAD1 APEX1 PHF14 MPHOSPH8 CHD7 XPC MED1 SPEN AFF4 | 5.89e-09 | 495 | 78 | 14 | int:H3C3 |
| Interaction | RNF113A interactions | H1-10 RPL29 ABCF1 NOP56 TCOF1 RBBP6 MATR3 H1-2 H1-3 LARS1 H1-4 H1-5 EIF5B APEX1 NCL RRBP1 | 7.45e-09 | 692 | 78 | 16 | int:RNF113A |
| Interaction | BTF3 interactions | RPL29 NOP56 MAP1B TCOF1 ANLN MATR3 H1-2 H1-4 H1-5 PSMC1 H1-1 MPHOSPH8 NCL CHD7 RPS25 RRBP1 IFI16 | 8.09e-09 | 799 | 78 | 17 | int:BTF3 |
| Interaction | H2BC13 interactions | 8.27e-09 | 210 | 78 | 10 | int:H2BC13 | |
| Interaction | RRP15 interactions | 9.68e-09 | 157 | 78 | 9 | int:RRP15 | |
| Interaction | PAF1 interactions | 9.91e-09 | 214 | 78 | 10 | int:PAF1 | |
| Interaction | IMP4 interactions | 1.29e-08 | 113 | 78 | 8 | int:IMP4 | |
| Interaction | RPS16 interactions | H1-10 RPL29 NOP56 ANLN KTN1 H1-3 LARS1 H1-4 H1-5 PSMC1 HMGB1 H1-1 NCL RPS25 RRBP1 NMT1 | 1.41e-08 | 724 | 78 | 16 | int:RPS16 |
| Interaction | MIDN interactions | H1-10 RPL29 NOP56 TCOF1 SLC16A1 DDX52 MATR3 H1-2 H1-3 H1-4 PSMC1 HMGN1 NCL RPS25 PPIB | 1.46e-08 | 626 | 78 | 15 | int:MIDN |
| Interaction | PARP1 interactions | RPL29 C9orf43 MED19 NOP56 NCKAP1 ANLN DDX52 H1-2 H1-3 H1-5 APEX1 HMGB1 PHF14 HMGN1 H1-1 NCL CHD7 XPC MED1 IFI16 AFF4 | 1.67e-08 | 1316 | 78 | 21 | int:PARP1 |
| Interaction | RPL6 interactions | RPL29 ABCF1 NOP56 ANLN MATR3 H1-2 H1-3 H1-4 HMGB1 H1-1 NCL RPS25 RRBP1 IFI16 MRPL1 | 1.84e-08 | 637 | 78 | 15 | int:RPL6 |
| Interaction | NSD1 interactions | 1.94e-08 | 119 | 78 | 8 | int:NSD1 | |
| Interaction | BIRC3 interactions | H1-10 RPL29 ABCF1 NOP56 NCKAP1 TCOF1 SLC16A1 DDX52 MATR3 KTN1 H1-2 LARS1 PSMC1 EIF5B HMGB1 MPHOSPH8 NCL RPS25 RRBP1 SPEN PPIB | 2.11e-08 | 1334 | 78 | 21 | int:BIRC3 |
| Interaction | AATF interactions | H1-10 NOP56 ANLN DDX52 MATR3 H1-2 H1-3 H1-4 H1-1 NCL RPS25 IFI16 | 2.14e-08 | 376 | 78 | 12 | int:AATF |
| Interaction | CTCF interactions | H1-10 NOP56 ATRX MAP1B KTN1 H1-3 H1-4 HMGB1 H1-1 NCL CHD7 RPS25 IFI16 | 2.26e-08 | 461 | 78 | 13 | int:CTCF |
| Interaction | H2AC21 interactions | 2.32e-08 | 234 | 78 | 10 | int:H2AC21 | |
| Interaction | H1-5 interactions | H1-10 C9orf43 AKAP5 ANLN H1-2 H1-3 H1-4 H1-5 HMGB1 H1-1 NCL RPS25 AFF4 | 2.38e-08 | 463 | 78 | 13 | int:H1-5 |
| Interaction | TAAR3P interactions | 2.58e-08 | 9 | 78 | 4 | int:TAAR3P | |
| Interaction | KCNA3 interactions | NOP56 MAP1B NCKAP1 TCOF1 SLC16A1 RBBP6 KTN1 LARS1 H1-4 PSMC1 EIF5B CHD9 CHD2 RPS25 RRBP1 SPEN PPIB | 2.88e-08 | 871 | 78 | 17 | int:KCNA3 |
| Interaction | RPL4 interactions | H1-10 RPL29 NOP56 ANLN DDX52 MATR3 KTN1 H1-4 H1-5 APEX1 HMGB1 H1-1 NCL RPS25 IFI16 SPEN | 2.98e-08 | 764 | 78 | 16 | int:RPL4 |
| Interaction | H2BC18 interactions | 3.18e-08 | 180 | 78 | 9 | int:H2BC18 | |
| Interaction | NOC3L interactions | 3.44e-08 | 244 | 78 | 10 | int:NOC3L | |
| Interaction | NCAPH interactions | 3.50e-08 | 315 | 78 | 11 | int:NCAPH | |
| Interaction | CEBPA interactions | ABCF1 NOP56 ANLN RTF2 MATR3 H1-2 LARS1 H1-5 PSMC1 EIF5B APEX1 HMGB1 CHD9 HMGN1 CHD7 RPS25 MED1 IFI16 SPEN PPIB | 3.56e-08 | 1245 | 78 | 20 | int:CEBPA |
| Interaction | RRP12 interactions | H1-10 NOP56 ANLN H1-2 H1-4 H1-5 EIF5B APEX1 H1-1 IFI16 GOLGA2 | 4.11e-08 | 320 | 78 | 11 | int:RRP12 |
| Interaction | HDGF interactions | 4.25e-08 | 321 | 78 | 11 | int:HDGF | |
| Interaction | RPL31 interactions | H1-10 RPL29 NOP56 TCOF1 ANLN DDX52 H1-2 H1-3 H1-4 H1-5 HMGB1 NCL RPS25 RRBP1 NMT1 | 4.36e-08 | 680 | 78 | 15 | int:RPL31 |
| Interaction | RPL10A interactions | RPL29 NOP56 ANLN MATR3 H1-4 H1-5 HMGB1 H1-1 NCL RPS25 RRBP1 IFI16 SPEN | 4.63e-08 | 490 | 78 | 13 | int:RPL10A |
| Interaction | UTP23 interactions | 5.30e-08 | 191 | 78 | 9 | int:UTP23 | |
| Interaction | H1-0 interactions | 5.41e-08 | 256 | 78 | 10 | int:H1-0 | |
| Interaction | MEN1 interactions | H1-10 RPL29 ATRX TCOF1 RBBP6 ANLN DDX52 MATR3 KTN1 EIF5B APEX1 XPC RPS25 MED1 IFI16 SPEN GOLGA2 AFF4 | 5.56e-08 | 1029 | 78 | 18 | int:MEN1 |
| Interaction | ENO1 interactions | CYLC1 RPL29 NOP56 MAP1B ANLN H1-3 EIF5B GATAD1 HMGB1 H1-1 MPHOSPH8 RPS25 LONRF3 IFI16 PPIB | 6.49e-08 | 701 | 78 | 15 | int:ENO1 |
| Interaction | NOP2 interactions | NOP56 ANLN DDX52 MATR3 H1-2 H1-4 H1-5 APEX1 HMGB1 H1-1 MPHOSPH8 IFI16 | 6.49e-08 | 416 | 78 | 12 | int:NOP2 |
| Interaction | HMGA1 interactions | H1-10 ANLN H1-2 H1-3 H1-4 H1-5 APEX1 HMGB1 PHF14 NCL XPC SPEN | 7.02e-08 | 419 | 78 | 12 | int:HMGA1 |
| Interaction | SERBP1 interactions | NOP56 ATRX MAP1B TCOF1 SLC16A1 ANLN DDX52 KTN1 H1-2 H1-3 LARS1 H1-4 H1-5 PSMC1 H1-1 NCL RPS25 RRBP1 IFI16 NMT1 MRPL1 | 7.14e-08 | 1432 | 78 | 21 | int:SERBP1 |
| Interaction | IFI16 interactions | H1-10 ABCF1 NOP56 MAP1B ANLN DDX52 MATR3 KTN1 H1-2 H1-3 H1-4 PHF14 MPHOSPH8 NCL IFI16 | 8.25e-08 | 714 | 78 | 15 | int:IFI16 |
| Interaction | CHD4 interactions | H1-10 ABCF1 NOP56 TCOF1 RBBP6 DDX52 MATR3 H1-2 H1-4 APEX1 PHF14 H1-1 NCL RPS25 RRBP1 IFI16 SPEN | 8.41e-08 | 938 | 78 | 17 | int:CHD4 |
| Interaction | BAP1 interactions | H1-10 RPL29 ABCF1 NOP56 MAP1B NCKAP1 TCOF1 MATR3 H1-2 CAST LARS1 PSMC1 EIF5B APEX1 HMGB1 NCL RPS25 MDK NMT1 PPIB | 8.65e-08 | 1314 | 78 | 20 | int:BAP1 |
| Interaction | RRS1 interactions | 8.83e-08 | 345 | 78 | 11 | int:RRS1 | |
| Interaction | CUL7 interactions | H1-10 RPL29 BRPF3 NOP56 MAP1B TCOF1 MATR3 H1-4 EIF5B H1-1 NCL RPS25 LONRF3 RRBP1 SPEN PPIB | 1.19e-07 | 845 | 78 | 16 | int:CUL7 |
| Interaction | FBXW7 interactions | H1-10 RPL29 MED19 ABCF1 NOP56 DDX52 MATR3 KTN1 LARS1 H1-4 H1-5 EIF5B NCL RPS25 MED1 SHOC2 IFI16 NMT1 GOLGA2 | 1.29e-07 | 1215 | 78 | 19 | int:FBXW7 |
| Interaction | HNRNPD interactions | H1-10 ATRX MAP1B ANLN MATR3 H1-2 H1-3 H1-4 H1-5 H1-1 NCL ANKRD12 IFI16 MRPL1 | 1.39e-07 | 638 | 78 | 14 | int:HNRNPD |
| Interaction | RPL8 interactions | RPL29 NOP56 ANLN MATR3 H1-2 H1-5 HMGB1 H1-1 NCL CHD7 RPS25 RRBP1 IFI16 | 1.40e-07 | 539 | 78 | 13 | int:RPL8 |
| Interaction | SIRT7 interactions | H1-10 ABCF1 NOP56 MAP1B NCKAP1 TCOF1 DDX52 H1-3 H1-4 EIF5B H1-1 CHD2 NCL CHD7 SPEN | 1.41e-07 | 744 | 78 | 15 | int:SIRT7 |
| Interaction | H3-4 interactions | H1-10 BRPF3 ABCF1 KDM5A H1-2 H1-3 H1-4 H1-5 GATAD1 H1-1 NCL PPIB | 1.45e-07 | 448 | 78 | 12 | int:H3-4 |
| Interaction | B3GNT2 interactions | H1-10 RPL29 ABCF1 MAP1B KTN1 H1-4 H1-5 PSMC1 EIF5B NCL RRBP1 IFI16 PPIB | 1.49e-07 | 542 | 78 | 13 | int:B3GNT2 |
| Interaction | WDR5 interactions | H1-10 ABCF1 NCKAP1 KDM5A ANLN MATR3 KTN1 H1-2 H1-4 APEX1 HMGB1 H1-1 NCL CHD7 RRBP1 NMT1 PPIB GOLGA2 | 1.54e-07 | 1101 | 78 | 18 | int:WDR5 |
| Interaction | YBX1 interactions | NOP56 RBBP6 ANLN MATR3 H1-2 H1-3 H1-4 H1-5 APEX1 H1-1 NCL RRBP1 IFI16 NMT1 MRPL1 | 1.61e-07 | 752 | 78 | 15 | int:YBX1 |
| Interaction | CBX3 interactions | BRPF3 ATRX TCOF1 RBBP6 ANLN H1-4 EIF5B HMGB1 CHD9 CHD7 XPC MED1 IFI16 SPEN | 1.62e-07 | 646 | 78 | 14 | int:CBX3 |
| Interaction | BMS1 interactions | 1.64e-07 | 218 | 78 | 9 | int:BMS1 | |
| Interaction | UTP3 interactions | 1.68e-07 | 157 | 78 | 8 | int:UTP3 | |
| Interaction | RPL11 interactions | H1-10 RPL29 NOP56 MAP1B TCOF1 ANLN KTN1 H1-2 H1-4 HMGB1 NCL CHD7 RPS25 RRBP1 | 1.81e-07 | 652 | 78 | 14 | int:RPL11 |
| Interaction | H2AZ1 interactions | ABCF1 NCKAP1 ANLN H1-2 APEX1 HMGB1 PHF14 H1-1 XPC SLCO6A1 AFF4 | 1.83e-07 | 371 | 78 | 11 | int:H2AZ1 |
| Interaction | COL5A1 interactions | 1.90e-07 | 65 | 78 | 6 | int:COL5A1 | |
| Interaction | RPL14 interactions | RPL29 NOP56 MAP1B ANLN DDX52 MATR3 H1-4 H1-5 APEX1 HMGB1 NCL RPS25 SLCO6A1 | 1.91e-07 | 554 | 78 | 13 | int:RPL14 |
| Cytoband | 20p12 | 2.63e-04 | 14 | 79 | 2 | 20p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 5.04e-04 | 378 | 79 | 5 | chr6p22 | |
| Cytoband | 1p12 | 8.55e-04 | 25 | 79 | 2 | 1p12 | |
| Cytoband | 6p21.3 | 9.36e-04 | 250 | 79 | 4 | 6p21.3 | |
| Cytoband | Xq21.1 | 1.49e-03 | 33 | 79 | 2 | Xq21.1 | |
| GeneFamily | Histones | 6.84e-07 | 116 | 49 | 6 | 864 | |
| GeneFamily | DNA helicases | 1.24e-05 | 17 | 49 | 3 | 1167 | |
| GeneFamily | PHD finger proteins | 1.03e-04 | 90 | 49 | 4 | 88 | |
| GeneFamily | Canonical high mobility group | 3.90e-04 | 11 | 49 | 2 | 511 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 4.67e-04 | 12 | 49 | 2 | 1243 | |
| GeneFamily | Cyclins|Mediator complex | 3.60e-03 | 33 | 49 | 2 | 1061 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 9.62e-09 | 90 | 78 | 7 | M39250 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | NOP56 ATRX SLC16A1 RBBP6 ANLN DDX52 MATR3 CAST LARS1 PLCB1 EIF5B IFI16 AFF4 | 1.97e-07 | 721 | 78 | 13 | M10237 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.37e-07 | 295 | 78 | 9 | M39121 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 3.70e-07 | 311 | 78 | 9 | M40024 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | WAS NOP56 TCOF1 RBBP6 DDX52 MATR3 CAST H1-4 EIF5B GATAD1 APEX1 HMGN1 NCL XPC RPS25 MED1 IFI16 | 5.65e-07 | 1394 | 78 | 17 | M9585 |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 6.26e-07 | 165 | 78 | 7 | M43617 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | RPL29 ABCF1 WAS ATRX TCOF1 RTF2 H1-2 PSMC1 EIF5B HMGB1 HMGN1 NCL RPS25 RRBP1 PPIB | 1.20e-06 | 1144 | 78 | 15 | MM3843 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.34e-06 | 363 | 78 | 9 | M41103 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | RPL29 NOP56 ANLN H1-3 H1-4 H1-5 APEX1 HMGB1 HMGN1 H1-1 NCL MDK IFI16 | 2.12e-06 | 891 | 78 | 13 | M41654 |
| Coexpression | TBK1.DF_DN | 2.21e-06 | 286 | 78 | 8 | M2864 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 2.35e-06 | 389 | 78 | 9 | M6520 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 2.50e-06 | 203 | 78 | 7 | MM3795 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 3.55e-06 | 305 | 78 | 8 | M40025 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATRX MAP1B NCKAP1 MATR3 KTN1 PLCB1 CHD9 MPHOSPH8 CHD7 XPC ANKRD12 SHOC2 AFF4 | 4.08e-06 | 946 | 78 | 13 | M39169 |
| Coexpression | TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL | 1.71e-05 | 629 | 78 | 10 | M41652 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 2.45e-05 | 656 | 78 | 10 | M18979 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DN | 2.74e-05 | 197 | 78 | 6 | M4946 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | WAS ATRX KDM5A RBBP6 MATR3 KTN1 HMGB1 HMGN1 MPHOSPH8 CHD2 RPS25 MED1 IFI16 PNISR SPEN | 2.92e-05 | 1492 | 78 | 15 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 4.37e-05 | 432 | 78 | 8 | M41149 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 4.89e-05 | 133 | 78 | 5 | M1447 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 5.83e-05 | 138 | 78 | 5 | MM1151 | |
| Coexpression | CARD_MIR302A_TARGETS | 8.33e-05 | 77 | 78 | 4 | M2208 | |
| Coexpression | LI_WILMS_TUMOR_ANAPLASTIC_DN | 8.69e-05 | 5 | 78 | 2 | M1216 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 9.20e-05 | 79 | 78 | 4 | M7102 | |
| Coexpression | FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1 | 1.12e-04 | 254 | 78 | 6 | M41705 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.28e-04 | 163 | 78 | 5 | M8235 | |
| Coexpression | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN | 1.30e-04 | 33 | 78 | 3 | M7429 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.39e-04 | 380 | 78 | 7 | M41703 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN | 1.42e-04 | 34 | 78 | 3 | M40965 | |
| Coexpression | LI_DCP2_BOUND_MRNA | 1.46e-04 | 89 | 78 | 4 | M2188 | |
| Coexpression | FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL | 1.69e-04 | 274 | 78 | 6 | M41712 | |
| Coexpression | HSIAO_HOUSEKEEPING_GENES | 1.82e-04 | 397 | 78 | 7 | M11197 | |
| Coexpression | ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE | 2.04e-04 | 97 | 78 | 4 | M39214 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_8HR | 2.14e-04 | 39 | 78 | 3 | M1641 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.21e-04 | 856 | 78 | 10 | M4500 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.45e-04 | 417 | 78 | 7 | M39224 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | 2.53e-04 | 419 | 78 | 7 | MM3768 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_8HR | 2.68e-04 | 42 | 78 | 3 | MM691 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 2.68e-04 | 714 | 78 | 9 | M1744 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.75e-04 | 300 | 78 | 6 | M8702 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN | 3.01e-04 | 196 | 78 | 5 | M10002 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 3.09e-04 | 197 | 78 | 5 | M9916 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 3.16e-04 | 198 | 78 | 5 | MM17083 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 3.23e-04 | 199 | 78 | 5 | M4473 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP | 3.31e-04 | 200 | 78 | 5 | M3620 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DN | 3.31e-04 | 200 | 78 | 5 | M4949 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN | 3.31e-04 | 200 | 78 | 5 | M3640 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP | 3.31e-04 | 200 | 78 | 5 | M8527 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN | 3.31e-04 | 200 | 78 | 5 | M8847 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 3.31e-04 | 200 | 78 | 5 | M6055 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP | 3.31e-04 | 200 | 78 | 5 | M5680 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 3.58e-04 | 444 | 78 | 7 | M41713 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | KIF9 NOP56 ANLN MYT1 CAST H1-3 LARS1 PSMC1 EIF5B APEX1 NCL MRPL1 | 3.60e-04 | 1271 | 78 | 12 | M39197 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 3.63e-04 | 911 | 78 | 10 | M40038 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 3.75e-04 | 318 | 78 | 6 | M41707 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 4.31e-04 | 458 | 78 | 7 | M40010 | |
| Coexpression | HEVNER_CORTEX_APICAL_INTERMEDIATE_PROGENITOR_CELLS | 5.66e-04 | 12 | 78 | 2 | MM398 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | 5.68e-04 | 792 | 78 | 9 | M12113 | |
| Coexpression | FISCHER_DREAM_TARGETS | 5.88e-04 | 969 | 78 | 10 | M149 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | 5.98e-04 | 484 | 78 | 7 | M14665 | |
| Coexpression | RICKMAN_METASTASIS_UP | 6.22e-04 | 350 | 78 | 6 | M9752 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 6.25e-04 | 230 | 78 | 5 | M11563 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX11 ABCF1 WAS TTC41P NOP56 ATRX MAP1B TCOF1 SLC16A1 RBBP6 ANLN KTN1 RAD54B EIF5B CHD9 PHF14 H1-1 MPHOSPH8 NCL CHD7 NMT1 PNISR | 7.53e-09 | 1459 | 78 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX11 ATRX KDM5A TRO KTN1 GATAD1 HMGB1 CHD9 HMGN1 CHD2 NCL CHD7 PNISR | 4.50e-07 | 629 | 78 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ABCF1 TTC41P NOP56 ATRX TCOF1 SLC16A1 RBBP6 ANLN KTN1 RAD54B EIF5B CHD9 PHF14 H1-1 MPHOSPH8 NCL NMT1 PNISR | 5.04e-07 | 1257 | 78 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.20e-07 | 137 | 78 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ATRX MAP1B ING1 KDM5A TRO MATR3 GATAD1 HMGB1 CHD9 CHD2 CHD7 PNISR | 1.69e-06 | 595 | 78 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCF1 ATRX MAP1B RBBP6 KTN1 RAD54B PHF14 MPHOSPH8 CHD2 NCL CHD7 NMT1 PNISR AFF4 | 1.77e-06 | 831 | 78 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.08e-06 | 311 | 78 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.19e-06 | 232 | 78 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | RPL29 BRPF3 ATRX SLC16A1 TRO RTF2 H1-2 H1-3 H1-4 H1-5 CHD9 HMGN1 NCL CHD7 MDK | 2.45e-06 | 983 | 78 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SOX11 ABCF1 ATRX MAP1B TCOF1 RBBP6 MYT1 KTN1 PHF14 MPHOSPH8 CHD2 NCL CHD7 NMT1 PNISR | 2.64e-06 | 989 | 78 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | H1-10 RPL29 ABCF1 NOP56 MAP1B TCOF1 SLC16A1 KTN1 H1-4 H1-5 APEX1 MPHOSPH8 NCL CHD7 BAHCC1 | 2.70e-06 | 991 | 78 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 2.87e-06 | 108 | 78 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MED19 ABCF1 MAP1B ANLN DDX52 KTN1 EIF5B MPHOSPH8 NCL CHD7 NMT1 | 3.76e-06 | 532 | 78 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | SOX11 H1-10 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 APEX1 H1-1 NCL CHD7 BAHCC1 | 4.65e-06 | 1175 | 78 | 16 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.25e-06 | 469 | 78 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ABCF1 MAP1B RBBP6 DDX52 MYT1 KTN1 EIF5B PHF14 MPHOSPH8 CHD2 NCL CHD7 NMT1 GOLGA2 | 1.22e-05 | 983 | 78 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 1.23e-05 | 491 | 78 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 1.34e-05 | 496 | 78 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.09e-05 | 316 | 78 | 8 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCF1 MAP1B RBBP6 KTN1 EIF5B PHF14 MPHOSPH8 CHD2 CHD7 ANKRD12 NMT1 | 2.60e-05 | 654 | 78 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.73e-05 | 328 | 78 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX11 ABCF1 WAS TTC41P ATRX MAP1B KDM5A RAD54B CHD9 PHF14 H1-1 MPHOSPH8 CHD7 GOLGA2 | 2.82e-05 | 1060 | 78 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K0 | SOX11 H1-10 SLC16A1 RTF2 H1-2 H1-4 H1-5 APEX1 H1-1 MDK PPIB BAHCC1 | 3.41e-05 | 802 | 78 | 12 | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K0 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | SOX11 RPL29 NOP56 MAP1B SLC16A1 KTN1 RAD54B H1-4 H1-1 MPHOSPH8 NCL CHD7 RPS25 MRPL1 | 3.46e-05 | 1080 | 78 | 14 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.01e-05 | 564 | 78 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | SOX11 H1-10 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 APEX1 H1-1 NCL CHD7 BAHCC1 | 5.23e-05 | 1429 | 78 | 16 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | SOX11 H1-10 NOP56 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 APEX1 H1-1 CHD7 MDK BAHCC1 | 5.39e-05 | 1125 | 78 | 14 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K4 | SOX11 RPL29 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 PLCB1 APEX1 H1-1 NCL MRPL1 | 5.58e-05 | 983 | 78 | 13 | facebase_RNAseq_e9.5_FaceMes_2500_K4 |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_250 | 5.80e-05 | 112 | 78 | 5 | Facebase_ST1_e10.5_MaxilArch_250 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 6.34e-05 | 186 | 78 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.35e-05 | 191 | 78 | 6 | gudmap_kidney_P2_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.56e-05 | 192 | 78 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 7.56e-05 | 192 | 78 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | SOX11 RPL29 ABCF1 NOP56 TCOF1 SLC16A1 KTN1 EIF5B APEX1 MPHOSPH8 NCL CHD7 RPS25 MRPL1 | 7.78e-05 | 1164 | 78 | 14 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 8.03e-05 | 493 | 78 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 9.40e-05 | 124 | 78 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.72e-05 | 291 | 78 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | SOX11 RPL29 ABCF1 NOP56 MAP1B TCOF1 SLC16A1 KTN1 EIF5B APEX1 MPHOSPH8 NCL CHD7 RPS25 MRPL1 | 9.92e-05 | 1347 | 78 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.06e-04 | 204 | 78 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | SOX11 RPL29 NOP56 MAP1B SLC16A1 KTN1 RAD54B H1-4 H1-1 MPHOSPH8 NCL CHD7 RPS25 MRPL1 | 1.09e-04 | 1202 | 78 | 14 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.17e-04 | 300 | 78 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | SOX11 RPL29 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 PLCB1 APEX1 H1-1 NCL CHD7 MRPL1 | 1.35e-04 | 1226 | 78 | 14 | facebase_RNAseq_e9.5_FaceMes_2500 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.91e-04 | 348 | 78 | 7 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.46e-04 | 164 | 78 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.56e-04 | 165 | 78 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | 3.99e-04 | 484 | 78 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | SOX11 H1-10 NOP56 TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 APEX1 H1-1 CHD7 MDK BAHCC1 | 4.25e-04 | 1371 | 78 | 14 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | SOX11 RPL29 ABCF1 NOP56 MAP1B TCOF1 SLC16A1 KTN1 RAD54B H1-4 EIF5B H1-1 MPHOSPH8 NCL | 4.25e-04 | 1371 | 78 | 14 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 4.45e-04 | 492 | 78 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 4.45e-04 | 492 | 78 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 4.82e-04 | 498 | 78 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_100 | 4.87e-04 | 99 | 78 | 4 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K0 | SOX11 H1-10 NOP56 MAP1B SLC16A1 RAD54B H1-4 H1-5 APEX1 CHD7 MDK | 5.49e-04 | 926 | 78 | 11 | facebase_RNAseq_e10.5_OlfacPit_2500_K0 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ABCF1 WAS TTC41P NOP56 ATRX ING1 EIF5B APEX1 CHD9 PHF14 HMGN1 NCL CHD7 | 5.51e-04 | 1241 | 78 | 13 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.56e-04 | 780 | 78 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX11 ABCF1 WAS TTC41P ATRX MAP1B KDM5A RAD54B CHD9 PHF14 H1-1 MPHOSPH8 CHD7 GOLGA2 | 5.79e-04 | 1414 | 78 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_200 | 5.88e-04 | 10 | 78 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 7.24e-04 | 110 | 78 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.00e-04 | 298 | 78 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 8.26e-04 | 973 | 78 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | H1-10 RPL29 SLC16A1 H1-2 H1-3 H1-4 H1-5 LAMA4 APEX1 H1-1 MDK PPIB BAHCC1 | 8.38e-04 | 1298 | 78 | 13 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 8.69e-04 | 979 | 78 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.12e-04 | 203 | 78 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | SOX11 RPL29 ABCF1 ATRX RTF2 PHF14 MPHOSPH8 CHD2 NCL CHD7 AFF4 | 9.13e-04 | 985 | 78 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_4 | 1.01e-03 | 13 | 78 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.07e-03 | 315 | 78 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.13e-03 | 124 | 78 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | SOX11 H1-10 MAP1B TCOF1 SLC16A1 H1-2 H1-3 H1-4 H1-5 H1-1 CHD7 BAHCC1 | 1.25e-03 | 1187 | 78 | 12 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.35e-03 | 130 | 78 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX11 BRPF3 ABCF1 WAS ATRX MAP1B SLC16A1 KTN1 RAD54B CHD9 PHF14 MPHOSPH8 CHD7 | 1.37e-03 | 1370 | 78 | 13 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.47e-03 | 133 | 78 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_500 | 1.47e-03 | 226 | 78 | 5 | Facebase_ST1_e10.5_MaxilArch_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_500 | 1.55e-03 | 16 | 78 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 1.67e-03 | 749 | 78 | 9 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#2_top-relative-expression-ranked_500 | 1.72e-03 | 139 | 78 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.86e-03 | 142 | 78 | 4 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 1.96e-03 | 482 | 78 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 1.98e-03 | 483 | 78 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.13e-03 | 776 | 78 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 2.19e-03 | 19 | 78 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | NOP56 ATRX MAP1B KDM5A RBBP6 H1-4 EIF5B PHF14 MPHOSPH8 CHD2 NCL ANKRD12 RRBP1 NMT1 PNISR | 8.32e-21 | 197 | 78 | 15 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.10e-12 | 198 | 78 | 10 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.50e-11 | 192 | 78 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 6.61e-11 | 196 | 78 | 9 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 6.61e-11 | 196 | 78 | 9 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.92e-11 | 200 | 78 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-09 | 186 | 78 | 8 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-09 | 186 | 78 | 8 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.29e-09 | 199 | 78 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-09 | 200 | 78 | 8 | b340b6acf675c75adffb98e560080f966571f594 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.38e-09 | 200 | 78 | 8 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.38e-09 | 200 | 78 | 8 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-09 | 200 | 78 | 8 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.38e-09 | 200 | 78 | 8 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.38e-09 | 200 | 78 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-08 | 176 | 78 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-08 | 191 | 78 | 7 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-08 | 192 | 78 | 7 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 4.72e-08 | 192 | 78 | 7 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 5.07e-08 | 194 | 78 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.25e-08 | 195 | 78 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.44e-08 | 196 | 78 | 7 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 5.44e-08 | 196 | 78 | 7 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.44e-08 | 196 | 78 | 7 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.44e-08 | 196 | 78 | 7 | f9a7d62684435f7c8a1205e2d0b2af0f6104a2dd | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.63e-08 | 197 | 78 | 7 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 5.83e-08 | 198 | 78 | 7 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.03e-08 | 199 | 78 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.03e-08 | 199 | 78 | 7 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 6.25e-08 | 200 | 78 | 7 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 6.25e-08 | 200 | 78 | 7 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-08 | 200 | 78 | 7 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-07 | 128 | 78 | 6 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.42e-07 | 164 | 78 | 6 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.92e-07 | 167 | 78 | 6 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.65e-07 | 171 | 78 | 6 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-07 | 173 | 78 | 6 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-07 | 173 | 78 | 6 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.26e-07 | 174 | 78 | 6 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 8.67e-07 | 184 | 78 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 8.67e-07 | 184 | 78 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.95e-07 | 185 | 78 | 6 | 26ea60b6392410fab048f2e406a9860a018429cc | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-07 | 185 | 78 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 9.83e-07 | 188 | 78 | 6 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 9.83e-07 | 188 | 78 | 6 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 191 | 78 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 1.08e-06 | 191 | 78 | 6 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | 3'_v3-bone_marrow|World / Manually curated celltypes from each tissue | 1.08e-06 | 191 | 78 | 6 | 7b759831f1b1c8575c31f67d0d9eb11c6a833cf3 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.08e-06 | 191 | 78 | 6 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 191 | 78 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 191 | 78 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-06 | 192 | 78 | 6 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.11e-06 | 192 | 78 | 6 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-06 | 192 | 78 | 6 | 448b71c965e1b7addc6bccbcd6047cefda3d5b5a | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-06 | 192 | 78 | 6 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster | 1.11e-06 | 192 | 78 | 6 | bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 1.15e-06 | 193 | 78 | 6 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 194 | 78 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-06 | 194 | 78 | 6 | 3e90be6f5b1c5c83632e62941fb18d6a627ec1b5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 194 | 78 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.18e-06 | 194 | 78 | 6 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-06 | 194 | 78 | 6 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-06 | 195 | 78 | 6 | da8680a91648843901e456b5faef5e85039ade15 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 195 | 78 | 6 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.22e-06 | 195 | 78 | 6 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-06 | 196 | 78 | 6 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-06 | 196 | 78 | 6 | 3cf73b33330b9fca5c8abf03f2f0d8244245b522 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-06 | 197 | 78 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.29e-06 | 197 | 78 | 6 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.29e-06 | 197 | 78 | 6 | 0a63c81425beecde234e6b3eb30427617b89e1ff | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-GMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.29e-06 | 197 | 78 | 6 | 462e91dc51e363d64e1e02d7444a733838e032a5 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_Interneurons|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-06 | 198 | 78 | 6 | 5798640425cabf4ac517b7f96a9dfd32f6e5e7c5 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-06 | 198 | 78 | 6 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.33e-06 | 198 | 78 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 199 | 78 | 6 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 1.37e-06 | 199 | 78 | 6 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.37e-06 | 199 | 78 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 199 | 78 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 1.37e-06 | 199 | 78 | 6 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.37e-06 | 199 | 78 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 1.37e-06 | 199 | 78 | 6 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 78 | 6 | 0649a2c5b8b1f01bb4c4d1eb114cf78a32f8ccd8 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.37e-06 | 199 | 78 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 1.37e-06 | 199 | 78 | 6 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 78 | 6 | e3e28981783b922027cee7fe8863386b02c7c758 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-06 | 199 | 78 | 6 | 94baf00dad27964392c3fc34970a4e79d576d0d3 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.37e-06 | 199 | 78 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 1.41e-06 | 200 | 78 | 6 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 200 | 78 | 6 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.41e-06 | 200 | 78 | 6 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.41e-06 | 200 | 78 | 6 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.41e-06 | 200 | 78 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.41e-06 | 200 | 78 | 6 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 1.41e-06 | 200 | 78 | 6 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 6.47e-06 | 149 | 78 | 5 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.21e-07 | 49 | 58 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Neighborhood of FBL | 1.28e-04 | 146 | 58 | 6 | GNF2_FBL | |
| Computational | Neighborhood of APEX1 | 1.32e-04 | 92 | 58 | 5 | GNF2_APEX1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 127. | 3.55e-04 | 26 | 58 | 3 | MODULE_127 | |
| Computational | Neighborhood of ACTG1 | 5.30e-04 | 124 | 58 | 5 | GCM_ACTG1 | |
| Drug | Spkk | 7.33e-09 | 43 | 78 | 6 | CID000129363 | |
| Drug | Scriptaid | 1.45e-08 | 48 | 78 | 6 | CID000005186 | |
| Drug | 5-methyl-dCTP | 3.37e-08 | 55 | 78 | 6 | CID000161376 | |
| Drug | NSC-629231 | 3.37e-08 | 55 | 78 | 6 | CID000363885 | |
| Drug | In-G | 1.23e-07 | 170 | 78 | 8 | CID000446054 | |
| Drug | 3-tert-butylphenyl-N-methyl-carbamate | 1.44e-07 | 36 | 78 | 5 | CID000013072 | |
| Drug | heparin disaccharide iii-S | 1.66e-07 | 37 | 78 | 5 | CID000448838 | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.66e-07 | 196 | 78 | 8 | 7276_UP | |
| Drug | GH 5 | 4.55e-07 | 45 | 78 | 5 | CID000163897 | |
| Drug | N-myristoyl-rkrtlrrl | 5.09e-07 | 46 | 78 | 5 | CID003081274 | |
| Drug | belinostat | 7.78e-07 | 50 | 78 | 5 | CID006918638 | |
| Drug | CAS 1400-61-9 | 1.05e-06 | 53 | 78 | 5 | CID000004568 | |
| Drug | Clorgyline | 1.79e-06 | 168 | 78 | 7 | ctd:D003010 | |
| Drug | CGP 41251 | 1.93e-06 | 108 | 78 | 6 | CID000104937 | |
| Drug | SK-7041 | 1.95e-06 | 60 | 78 | 5 | CID006918714 | |
| Drug | gold sodium thiomalate | 2.30e-06 | 62 | 78 | 5 | CID000022318 | |
| Drug | AlCl3 | 2.51e-06 | 113 | 78 | 6 | CID000024012 | |
| Drug | F2-b | 3.15e-06 | 66 | 78 | 5 | CID000001700 | |
| Drug | AC1Q6AQ7 | 3.77e-06 | 188 | 78 | 7 | CID000005515 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 3.90e-06 | 189 | 78 | 7 | 2041_DN | |
| Drug | trifluoroethanol | 4.11e-06 | 123 | 78 | 6 | CID000006409 | |
| Drug | Kemptide | 4.31e-06 | 124 | 78 | 6 | CID000100074 | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 4.33e-06 | 192 | 78 | 7 | 4311_DN | |
| Drug | arsenic trioxide | 4.41e-06 | 468 | 78 | 10 | CID000014888 | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 4.48e-06 | 193 | 78 | 7 | 6427_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.48e-06 | 193 | 78 | 7 | 4305_DN | |
| Drug | syntide-2 | 4.52e-06 | 71 | 78 | 5 | CID005074902 | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A | 4.80e-06 | 195 | 78 | 7 | 1420_DN | |
| Drug | nalidixic acid | 4.87e-06 | 277 | 78 | 8 | CID000004421 | |
| Drug | chlorpropamide; Up 200; 100uM; MCF7; HG-U133A | 5.13e-06 | 197 | 78 | 7 | 141_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A | 5.30e-06 | 198 | 78 | 7 | 5609_DN | |
| Drug | AC1OCADI | 5.66e-06 | 130 | 78 | 6 | CID006914639 | |
| Drug | DADS | 5.92e-06 | 131 | 78 | 6 | CID000016590 | |
| Drug | Zlllal | 7.47e-06 | 613 | 78 | 11 | CID000107707 | |
| Drug | Trapoxin B | 7.66e-06 | 79 | 78 | 5 | CID000005532 | |
| Drug | Amphoterin | 8.32e-06 | 139 | 78 | 6 | CID003496889 | |
| Drug | C04378 | 9.20e-06 | 82 | 78 | 5 | CID000440315 | |
| Drug | 32 P | 1.01e-05 | 405 | 78 | 9 | CID000448772 | |
| Drug | 3-aminobenzamide | 1.61e-05 | 156 | 78 | 6 | CID000001645 | |
| Drug | LAQ824 | 1.61e-05 | 92 | 78 | 5 | CID006445533 | |
| Drug | 8-bromoguanosine | 1.70e-05 | 93 | 78 | 5 | CID000092977 | |
| Drug | polyarginine | 1.89e-05 | 95 | 78 | 5 | CID000072364 | |
| Drug | NSC23766 | 2.19e-05 | 98 | 78 | 5 | CID000409805 | |
| Drug | NaCl | 2.23e-05 | 564 | 78 | 10 | CID000005234 | |
| Drug | sodium butyrate | 2.34e-05 | 344 | 78 | 8 | CID005222465 | |
| Drug | testosterone enanthate | 2.63e-05 | 575 | 78 | 10 | ctd:C004648 | |
| Drug | NSC351140 | 2.94e-05 | 258 | 78 | 7 | CID000002210 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.98e-05 | 174 | 78 | 6 | 1302_UP | |
| Drug | Coal Tar | 3.23e-05 | 360 | 78 | 8 | ctd:D003033 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.28e-05 | 177 | 78 | 6 | 985_DN | |
| Drug | gamma-butyrolactone | 3.51e-05 | 108 | 78 | 5 | CID000007302 | |
| Drug | LBH589 | 3.67e-05 | 109 | 78 | 5 | CID006918837 | |
| Drug | geldanamycin | 4.00e-05 | 371 | 78 | 8 | ctd:C001277 | |
| Drug | SN-38 | 4.07e-05 | 184 | 78 | 6 | CID000104842 | |
| Drug | Apicidin | 4.36e-05 | 113 | 78 | 5 | CID000467801 | |
| Drug | mustard oil | 4.55e-05 | 114 | 78 | 5 | CID000005971 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.73e-05 | 189 | 78 | 6 | 4271_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 4.73e-05 | 189 | 78 | 6 | 5084_DN | |
| Drug | fluoride | 4.73e-05 | 278 | 78 | 7 | CID000014917 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.87e-05 | 190 | 78 | 6 | 4507_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 4.87e-05 | 190 | 78 | 6 | 4307_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.87e-05 | 190 | 78 | 6 | 4322_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 5.01e-05 | 191 | 78 | 6 | 4303_DN | |
| Drug | E-PEG | 5.03e-05 | 621 | 78 | 10 | CID000003310 | |
| Drug | Thimerosal | FSIP2 H1-10 ATRX SLC16A1 H1-3 LARS1 H1-4 HMGB1 CHD9 SHOC2 IFI16 SPEN MRPL1 AFF4 | 5.06e-05 | 1199 | 78 | 14 | ctd:D013849 |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 5.16e-05 | 192 | 78 | 6 | 1599_DN | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A | 5.16e-05 | 192 | 78 | 6 | 1778_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.31e-05 | 193 | 78 | 6 | 1051_DN | |
| Drug | 2c5o | 5.41e-05 | 284 | 78 | 7 | CID000447956 | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; PC3; HT_HG-U133A | 5.47e-05 | 194 | 78 | 6 | 7131_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.47e-05 | 194 | 78 | 6 | 4308_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.47e-05 | 194 | 78 | 6 | 4309_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.47e-05 | 194 | 78 | 6 | 4312_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 5.47e-05 | 194 | 78 | 6 | 2009_DN | |
| Drug | Dronabinol | ATRX MAP1B SLC16A1 H1-2 LARS1 MPHOSPH8 CHD2 ANKRD12 RRBP1 MDK PNISR SPEN | 5.61e-05 | 905 | 78 | 12 | ctd:D013759 |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 5.62e-05 | 195 | 78 | 6 | 3559_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A | 5.62e-05 | 195 | 78 | 6 | 1981_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.62e-05 | 195 | 78 | 6 | 3237_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.79e-05 | 196 | 78 | 6 | 7173_UP | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HG-U133A | 5.79e-05 | 196 | 78 | 6 | 1959_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HG-U133A | 5.79e-05 | 196 | 78 | 6 | 1909_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1698_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1903_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1931_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; PC3; HG-U133A | 5.95e-05 | 197 | 78 | 6 | 1923_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 6.12e-05 | 198 | 78 | 6 | 4837_DN | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | 6.12e-05 | 198 | 78 | 6 | 488_UP | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | 6.12e-05 | 198 | 78 | 6 | 427_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | 6.12e-05 | 198 | 78 | 6 | 594_UP | |
| Drug | HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A | 6.12e-05 | 198 | 78 | 6 | 436_DN | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A | 6.12e-05 | 198 | 78 | 6 | 4759_DN | |
| Drug | NaBu | 6.28e-05 | 122 | 78 | 5 | CID000052923 | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 2682_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 5604_UP | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.47e-05 | 200 | 78 | 6 | 4505_DN | |
| Drug | butane | 6.53e-05 | 123 | 78 | 5 | CID000007843 | |
| Drug | DB08668 | 7.36e-05 | 65 | 78 | 4 | CID011840990 | |
| Drug | butyrolactone I | 7.89e-05 | 128 | 78 | 5 | CID000123740 | |
| Drug | myristate | 9.37e-05 | 310 | 78 | 7 | CID000011005 | |
| Drug | AC1L9M5N | 9.46e-05 | 133 | 78 | 5 | CID000448618 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.94e-07 | 7 | 77 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 7.35e-05 | 165 | 77 | 5 | C0235874 | |
| Disease | brain infarction (implicated_via_orthology) | 3.64e-04 | 11 | 77 | 2 | DOID:3454 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.84e-04 | 152 | 77 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.10e-03 | 206 | 77 | 4 | C0152013 | |
| Disease | Micronuclei, Chromosome-Defective | 2.10e-03 | 26 | 77 | 2 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 2.10e-03 | 26 | 77 | 2 | C1449862 | |
| Disease | Adenoid Cystic Carcinoma | 2.30e-03 | 100 | 77 | 3 | C0010606 | |
| Disease | Hematopoetic Myelodysplasia | 2.61e-03 | 29 | 77 | 2 | C2713368 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAVAAKKFGPKSSKK | 271 | Q9Y2R4 | |
| TSPSDKVVKKGKKDK | 21 | Q8NE71 | |
| KKGKEEKSKGKAKPQ | 176 | Q8NE71 | |
| KTPGKKSISKDKAGK | 2086 | Q9P281 | |
| GKKAKKPAKAAAASK | 21 | Q02539 | |
| SKKLKKATGASKKSV | 136 | Q02539 | |
| KATGASKKSVKTPKK | 141 | Q02539 | |
| EKAPVKKKAAKKAGG | 16 | P16403 | |
| KKKAAKKAGGTPRKA | 21 | P16403 | |
| KKAKKPAAATVTKKV | 156 | P16403 | |
| KAKVAKPKKAAKSAA | 176 | P16403 | |
| KKPSSKGKKKESCSK | 91 | Q9ULD4 | |
| EIKKGKKDKKKPSST | 266 | Q14093 | |
| EKEKAKTPVAKKSGK | 246 | Q9UI46 | |
| PEAKKSKTAAKKNDK | 21 | P27695 | |
| PEKKKTKKEAGNKKS | 106 | Q6UB98 | |
| KEKKAKTATPKPKSS | 681 | Q9P2D1 | |
| KPKSSKKSSNKKPDS | 691 | Q9P2D1 | |
| AASAKKKKGSKKVTP | 71 | Q13319 | |
| TVGKKQPKKAEKAAA | 561 | Q9UHB7 | |
| CKPSKKKHKKWEGDA | 131 | Q9Y620 | |
| KPTKAGKDKSKASLE | 201 | P53985 | |
| GPEEAVGKSSSKKKK | 571 | O00567 | |
| VKKDSVAAGKPKEKG | 766 | P46821 | |
| KKDGSASAAAKKKLK | 701 | P43243 | |
| GKPDAAKKGVVKAEK | 166 | P09429 | |
| LSPANDTGAKKKKKK | 46 | P30419 | |
| KGKTSPKDKKGKKDV | 536 | A6NIV6 | |
| VAKKKDKVKKGGPGS | 21 | P21741 | |
| CTPKTKAKAKAKKGK | 126 | P21741 | |
| AKKTAAAGGKKVKKA | 186 | Q92522 | |
| AAGGKKVKKAAKPSV | 191 | Q92522 | |
| QKKDPSGLDKKKKTS | 886 | Q9NQW6 | |
| AAKAKSKTKLGPGEK | 2686 | Q5CZC0 | |
| KKSKDEKGGTPLKKD | 116 | P35663 | |
| EKGGTPLKKDSKKKG | 121 | P35663 | |
| TPKKEDATKAGKGKV | 401 | Q8N4P6 | |
| SEAAASKKKPGQKKS | 156 | Q86UP2 | |
| SKKKPGQKKSKNGSD | 161 | Q86UP2 | |
| KKKSGTKKDVPKSWL | 296 | Q92887 | |
| FSTKPGKKAKSKKTF | 486 | Q9HAQ2 | |
| GKKAKSKKTFKEPLS | 491 | Q9HAQ2 | |
| PTGAKKKKKIKNGSN | 41 | Q08379 | |
| SPASEGGCKKKKSKV | 261 | O94880 | |
| EKPLKVKGKDSSEKK | 1491 | P29375 | |
| VNKKSKKQTGKKGEP | 641 | Q9Y2A7 | |
| KKGKKAAATSAKKVV | 51 | P19338 | |
| KPKAKGDKTKRKNDG | 1011 | Q7Z6E9 | |
| NIKKSGKSFKCKKPT | 16 | A0A1B0GVM5 | |
| KKGTEEKKKPSDFKK | 986 | P46100 | |
| KKKGKKGKKDSSSSG | 1931 | P46100 | |
| KSKPKDKDSKKTKTC | 571 | Q3L8U1 | |
| EKSPAKKKATKKAAG | 16 | P16401 | |
| KKKATKKAAGAGAAK | 21 | P16401 | |
| NKKAASGEAKPKAKK | 111 | P16401 | |
| SGEAKPKAKKAGAAK | 116 | P16401 | |
| GATPKKAKKAAGAKK | 136 | P16401 | |
| GVKKVAKSPKKAKAA | 166 | P16401 | |
| AKPKAAKAKKAAAKK | 211 | P16401 | |
| KSAPAAEKKVSTKGK | 101 | Q8WUU5 | |
| KKKKKAKKASETSPF | 236 | Q96C57 | |
| ERKKSKDKKEKPKSG | 1416 | O14647 | |
| KDKKEKPKSGDAKSS | 1421 | O14647 | |
| IKKQEAKKKAKSDPG | 311 | Q8TAL5 | |
| KKAAKALKPKAGSEA | 41 | P24588 | |
| SGKPGDKKKEKKSLT | 121 | P20810 | |
| AQKRKKSTKEKAGPK | 126 | Q16666 | |
| AKPKAKKAGAAKAKK | 116 | P10412 | |
| KKAGAAKAKKPAGAA | 121 | P10412 | |
| KKPKKATGAATPKKS | 136 | P10412 | |
| KKAKKPAAAAGAKKA | 156 | P10412 | |
| GAKKAKSPKKAKAAK | 166 | P10412 | |
| EKTPVKKKAKKAGAT | 16 | P16402 | |
| AGTKKVAKSAKKVKT | 166 | P16402 | |
| NDGKSKDKPPKRKKA | 1001 | Q15648 | |
| KKAKAGKLKDKSKPD | 171 | Q99549 | |
| KPKASQNKKGGKSKD | 1421 | Q16363 | |
| ETPSDSDHKKKKKKK | 191 | A0JLT2 | |
| KVEAKPKKAAAKDKS | 31 | P05114 | |
| PKKAAAKDKSSDKKV | 36 | P05114 | |
| PKAKAKAKAKDQTKA | 121 | P47914 | |
| EKKTKKPKAAESVSK | 196 | Q9BY42 | |
| KGSSKKCGKLKAPAA | 161 | P35716 | |
| GDQSNPKSKKEKKKS | 1431 | Q13428 | |
| TKDSESPSQKKKKKK | 1466 | Q13428 | |
| KGKKSKAAAKAGSSK | 141 | Q9P2J5 | |
| SGTPKEKKAKTSKKK | 316 | Q9UK53 | |
| LEDKDSKSKKTAKPK | 116 | O60841 | |
| SAADEKKKGPKVTVK | 31 | P23284 | |
| KEPKTKGKDAKDGKK | 41 | Q9UQ13 | |
| KRKKAKSSVSKKPGE | 66 | Q86UG4 | |
| TRVGKKKKKTKGPDA | 31 | P62191 | |
| DPVNKSGGKAKKKKW | 21 | P62851 | |
| KLEKDKGKAKSPKEK | 156 | Q6Q759 | |
| KGKAKSPKEKKAPSA | 161 | Q6Q759 | |
| KSKKLESTGDPKKKE | 111 | Q9Y2B4 | |
| VHTGKKSKKTKKCGK | 246 | Q8N587 | |
| KKTKKGAKEKTPDEK | 51 | Q9BYD6 | |
| QEAPAKKKSGSKKKG | 621 | Q9P2E9 | |
| VAAKDKKPNKSKRSK | 1811 | Q96T58 | |
| KPKKASKAKKAANKA | 201 | Q12816 | |
| SPADKKRSGKKKISK | 221 | P42768 | |
| TISDKSKCAPGKGKK | 1171 | Q6P2S7 | |
| LEKSAKKDSKKKSEP | 966 | Q9NQ66 | |
| GSSKEKKAKKPKHSR | 766 | Q8TF01 | |
| LKGGPKKTKREKKAA | 916 | Q01831 | |
| PKAASSKTGKCQEKK | 406 | Q496Y0 | |
| AKKSGVKVAPTKDDK | 871 | Q01538 |